This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universidade Federal De Minas Gerais. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Fernanda Silva Torres: Innovator in Pharmaceutical Peptides
Introduction
Fernanda Silva Torres is a prominent inventor based in Belo Horizonte, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic peptides. Her work focuses on innovative solutions for medical conditions, showcasing her dedication to advancing healthcare.
Latest Patents
Fernanda holds a patent for a synthetic peptide known as PnTx(19). This peptide consists of 19 amino acids and is derived from the native toxin PnTx2-6 of the Phoneutria nigriventer spider. The patent details pharmaceutical compositions that utilize this peptide for the treatment of erectile dysfunction and enhancing erectile function. This innovative approach highlights her commitment to addressing critical health issues.
Career Highlights
Fernanda is affiliated with the Universidade Federal De Minas Gerais, where she contributes to research and development in the field of pharmaceuticals. Her academic background and research initiatives have positioned her as a key figure in her area of expertise. With 1 patent to her name, she continues to push the boundaries of scientific research.
Collaborations
Fernanda collaborates with esteemed colleagues such as Adriano Monteiro De Castro Pimenta and Flávia De Marco Almeida. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion
Fernanda Silva Torres exemplifies the spirit of innovation in the pharmaceutical field through her groundbreaking work on synthetic peptides. Her contributions not only advance scientific knowledge but also offer potential solutions for medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
